Novartis reported $3.66B in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Amgen AMGN:US USD 1.59B 78M
Astrazeneca AZN:US USD 2.12B 214M
AstraZeneca AZN:LN USD 2.12B 214M
Biogen BIIB:US USD 469.5M 14.5M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Canopy Growth Corp WEED:CN CAD 114.04M 2.53M
Catalent CTLT:US USD 764M 61M
Corcept Therapeutics CORT:US USD 1.34M 23K
Eli Lilly And LLY:US USD 1.58B 148.6M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Glaxosmithkline GSK:US GBP 2.39B 250M
Horizon Pharma HZNP:US USD 234.13M 3.92M
Johnson & Johnson JNJ:US USD 7.81B 95M
Lannett LCI:US USD 62.48M 3.85M
Merk MRK:US USD 3.43B 715M
Novartis NOVN:VX USD 3.66B 92M
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Perrigo Ordinary Shares PRGO:US USD 737.3M 12.3M
Pfizer PFE:US USD 6.09B 2.58B
Phibro Animal Health PAHC:US USD 163.88M 12.97M
Prestige Brands PBH:US USD 128.26M 11.32M
Supernus Pharmaceuticals SUPN:US USD 25.88M 5.42M
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
Valeant Pharmaceuticals VRX:CN USD 584M 7M
Zoetis ZTS:US USD 606M 14M